From Endpoint News: Blocking PD-L1 production ... immuno-oncology drug

From Endpoint News, January 16, 2019.

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-backed I/O drug

Tags: immuno-oncology

Category: News

Stay Informed

Learn how to find and retain the top talent in life sciences from the leader in executive search. Subscribe to our newsletter to stay informed.